Zimmer Biomet acquired Compression Therapy Concepts, provider of devices to prevent deep venous thrombosis following a variety of surgical procedures. CTC will operate as a wholly-owned subsidiary of Zimmer Biomet. Transaction terms were not disclosed.
The commercial operations of ISTO Technologies, an orthobiologics company, were acquired by private equity firm Thompson Street Capital Partners. Transaction terms were not disclosed.
AlloSource launched AlloFuse® Cortical Fibers and AlloFuse Fiber Boat demineralized cortical fiber allografts for a variety of spine and orthopaedic procedures.Â
curasan will invest in targeted expansion of sales and marketing activities in the U.S. and China. The company markets CERASORB® bone void filler products.
Titan Spine is amending its device warranty to provide a free replacement if any Endoskeleton® interbody fusion devices delaminate or generate particulate debris during implantation.Â
SI-BONE received FDA 510(k) clearance of a modified indication for the iFuse Implant System®, noting that clinical studies have demonstrated its ability to improve pain, patient function and quality of life.Â